Most Popular

NovaBay Pharmaceuticals A Ground Floor Opportunity, Analyst Expects 1350% Upside ($NBY)

NovaBay Pharmaceuticals Inc. (AMEX: NBY) stock is presenting a ground floor investment opportunity, so says an analyst at Ascendient Capital, who expects an over 1350% increase from current levels to $12 a share. That forecast isn’t blind ambition. The case is made after factoring in expected revenue increases, aggressive cost cutting, and faster market penetration by its innovative consumer eye, skin, and wound care products. (* share price from NASDAQ.com, 6/28/23, 9:52 AM EST) Reaching that bullish $12 price target

NovaBay Pharmaceuticals A Ground Floor Opportunity, Analyst Expects 1350% Upside ($NBY) Read More »

Nightfood Holdings

Nightfood Holdings Solving America’s $50 Billion Nighttime Snack Problem

Are you a late-night snacker? Do you work hard to eat right only to ruin a whole day of healthy choices with unhealthy snacks in the hours before bed? If so, you’re not alone. More than 80% of American adults snack regularly at night, with the average being 4 nights per week. That’s approximately one billion nighttime snacks consumed every single week. It’s estimated that a staggering $65 billion a year is spent on snacks consumed between dinner and bed.

Nightfood Holdings Solving America’s $50 Billion Nighttime Snack Problem Read More »